Agranulocytosis induced by loxapine in an elderly patient: A case study;Agranulocytose sous loxapine chez une personne âgée: Étude d'un cas

Therapie

Volumn 59, Issue 5, 2004, Pages 561-564

  Hehn, Michèle ^a,d   Labrune, Orianne ^b   Degouy, Arnaud ^a   Duchene, Francis ^b   Laroche, Martine ^a   Maloisel, Fréderic ^c   Simon, Gérard ^b   Kantelip, Jean Pierre ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b Centre Hospitalier Belfort Montbéliard   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d Centre Hospitalier de Saint Denis   (France)

Author keywords

Agranulocytosis; Elderly patient; Loxapine

Indexed keywords

ACICLOVIR; AMLODIPINE; C REACTIVE PROTEIN; CEFTRIAXONE; CIPROFLOXACIN; FERROUS SULFATE; HEMOGLOBIN; LOXAPINE; LOXAPINE SUCCINATE; OFLOXACIN; VALACICLOVIR;

AGED; AGRANULOCYTOSIS; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; CONFUSION; HUMAN; LABORATORY DIAGNOSIS; LEUKOCYTE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; THROMBOCYTE;

EID: 11144240505     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie:2004096     Document Type: Conference Paper

References (16)

1. Kaufmann DW, Kelly JP, Levy M, et al. The drug etiology of agranulocytosis: an update of the international agranulocytosis and aplastic anemia study. Pharmacoepidemiol Drug Saf 1993; 2: 525-9
2. Strom BL, Carson JL, Schinnar R, et al. Descriptive epidemiology of agranulocytosis. Arch Intern Med 1992; 152: 1475-80
3. Julia A, Olona M, Bueno J, et al. Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes. Br J Haematol 1991; 79: 366-71
4. Sedlacek SM, Rudolf PM, Kaehny WD. Amoxapine associated agranulocytosis with thrombocytosis occuring early during recovery. Am J Med 1986; 80 (3): 533-6
5. Christenson BC. Agranulocytosis associated with amoxapine. Am J Psychiatry 1983; 140 (7): 921-2
6. Simpson GM, Pi EH, Sramek JJ. Neuroleptic and antipsychotic drugs. Ch. 6. In: Duke MNG, Aronson JK, editors. Meyler's side effects of drugs. 14th ed. Amsterdam: Elsevier Science BV, 2000: 139-63
7. Benichou C, Solal-Celigny P. Standardization of definitions and criteria for causality assessment of adverse drug reactions: drug-induced blood cytopenias: report of an international consensus meeting. Nouv Rev Fr Hematol 1993; 33: 257-62
8. Ostrousky O, Meged S, Loewenthal R, et al. NQO2 gene is associated with clozapine-induced agranulocytosis. Tissue Antigens 2003; 62 (6): 483-91
9. Esposito D, Aouille J, Rouillon F, et al. Morning pseudoneutropenia during clozapine treatment. World J Biol Psychiatry 2003; 4 (4): 192-4
10. Jegouzo A, Gressier B, Frimat B, et al. Comparative oxidation of loxapine and clozapine by human neutrophils. Fundam Clin Pharmacol 1999; 13: 113-9
11. Munyon WH, Salo R, Briones DF. Cytotoxic effects of neuroleptic drugs. Psychopharmacology 1987; 91: 182-8
12. Andres E, Maloisel F, Kurtz JE, et al. Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature. Eur J Intern Med 2002; 13 (5): 324-8
13. Maloisel F, Andres E, Kaltenbach G, et al. Prognostic factors of hematologic recovery in nonchemotherapy drug-induced agranulocytosis. Haematologica 2003; 88 (4): 470-1
14. Sprikkelman A, de Wolf JT, Vellenga E. The application of hematopoietic growth factors in drug-induced agranulocytosis: review of 70 cases. Leukemia 1994; 8: 2031-6
15. Beauchesne MF, Shalansky SJ. Non chemotherapy drug induced agranulocytosis: a review of 118 patients treated with colony stimulating factors. Pharmacotherapy 1999; 19: 229-305
16. Fukata S, Kuma K, Sugawara M. Granulocyte colony stimulating factor does not improve recovery from antithyroid drug induced agranulocytosis: a prospective study. Thyroid 1999; 9: 29-31